Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming
Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming buy - large image1
Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming buy - image1
Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming buy - image2
Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming buy - image3
Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming buy - image4
Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming buy - image5
Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming buy - image6

Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming

TDS 2098 Inquiries

Unit Price:

$110/UNIT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Guangzhou

Brand:

ES

Packaging:

5mg,10mg/vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

peptides

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    we sale full list with peptide products , any other requirements just contact me!
    Name:Lily

    email: sjzes2@enshikj.com
    WhatsApp: +852 9681 6401

    Tirzepatide  is a peptide-based medication that has garnered significant attention in the field of diabetes management. As a member of the glucagon-like peptide-1 (GLP-1) receptor agonist class, Tirzepatide offers a novel approach to addressing the complexities of type 2 diabetes mellitus (T2DM). This peptide-based therapy has demonstrated promising results in clinical trials, showcasing its potential to revolutionize diabetes treatment.

      The therapeutic potential of Tirzepatide extends beyond glycemic control, with emerging evidence suggesting its utility in addressing comorbidities commonly associated with T2DM. Preclinical studies have indicated potential benefits of Tirzepatide in preserving beta-cell function, reducing inflammation, and improving cardiovascular function, highlighting its broader impact on metabolic health. These findings underscore the transformative role of peptide-based therapies like Tirzepatide in reshaping the landscape of diabetes care. The recommended starting dose and titration schedule may vary based on individual patient factors, including baseline glycemic control, renal function, and concomitant medications. Close monitoring of glycemic parameters and adherence to treatment guidelines are essential to optimize therapeutic outcomes and minimize the risk of adverse events.

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 1

    FUNCTION:

    The addition of GIP which anatagonizes the central effects of GLP-1 to cause nausea is designed to improve tolerability and also allow for more aggressive dosing with increased systemic exposure. A recent post-hoc analysis showed significantly decreased NASH-related biomarkers and increased adiponectin in patients with T2DM

      The weight-reducing actions of the GIPR-GLP1R co-agonist tirzepatide.Considerable interest is focused on the mechanisms of action of tirzepatide, a highly effective GIPR-GLP1R co-agonist that produces superior reductions in HbA1c and body weight, relative to that achieved with 1 mg once weekly of semaglutide in people with T2D. The GIPR is expressed in multiple regions of the mouse and human brain, in subsets of neurons and glial cells, with some hypothalamic and hindbrain cells exhibiting co-expression of the GIPR and GLP1R. Chemogenetic activation of GIPR + cells in the mouse hypothalamus acutely reduced food intake; however, co-administration of exendin-4 did not produce an additive reduction of food intake when compared to either intervention alone.

    Items Specifications
    Product Name Tirzepatide
    CAS 2023788-19-2
    Molecular Formula C225H348N48O68
    Appearance White Powder
    Application Weight loss
    MOQ 1g

    Product detials

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 2

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 3

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 4

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 5

    Our customers are all over the world, mainly selling in the United States, Canada, Australia, the United. Kingdom, the Ne therlands, Germany, France and other EU countries, Southeast Asia, South America, and Oceania. We also have many customers.
    Our business is based on honesty and mutual trust. Sincerely look forward to establishing long-term mutually beneficial business relationships with customers around the world.

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 6

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 7


    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 9

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 10

    \Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 11


                                                                                                                --------- our company------

    Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

    Shop Wholesale Label Peptides Retatrutide Manufacturer 10mg 30 40mg 60 retatrutid Janoshik Research Peptide-Detailed Image 12

    We supply large quantities of peptides.In addition to regular specifications, we can also customize according to customer requirements.
    The minimum order quantity is 1 box(10vials), we welcome customers to order samples for testing.Please contact us for COA or HPLC.
    We believe that as long as the quality is good enough will lead to long-term cooperation.Looking forward to your inquiry.

       FAQ

    Q1:How to send order?
    A:Send order list to us,we quote best price for you,then ship package out and offer tracking nubmer to you after payment send.

    Q2:Do you have samples for our reference?
    A:Sure,we can offer smaples,the customers will pay the freight.

    Q3:Any discount if order more?
    A:Sure,the price is negotiable,you can get much better price if order big quantity.

    Q4:What about the delivery time?
    A:Ship within 1-2 days after confirming payment (excluding Chinese holidays).5-7 days to arrive your address.

    Q5:What kind of payment terms do you accept?
    A:Payment can be made by Bank transfer, BTC,Credite Card,TT,Paypal,Alipay,Wechat,Visa,Mastercard,Appple Pay,Goolge Pay.


                                                               ------ Our Advantage ------

    1. Product Quality Assurance: We maintain stringent quality standards. Contact us for quality-related issues.

    2. Returns and Refunds: Notify us of damaged or incorrect products. Refer to our Returns and Refunds Policy.

    3. Technical Support: Reach our technical support team for assistance.

    4. Order Tracking: Receive tracking information for your order.

    5. Customer Feedback: Share your feedback with us.

    6. Updates and Notifications: Subscribe to our newsletter for updates


    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Certificates
    • Tirzepatide Reta Peptide LY3298176 CAS 2023788-19-2 10mg 20mg Vial Slimming Certificates 1 TDS

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides

    Location:

    Room 704#-A010, Building 11, Block 16, Liangzhu Street, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2025

    Company Certificates
    • Enshi Technology Co., Ltd.Examining report Examining report

    Our company is a modern advanced enterprise specializing in production and exportation of APIs, Pharmaceutical intermediates, plant extracts etc. Our products are widely used in medicine, health care products, cosmetics, nutritional supplements and food additives areas. Our factory covers an area of 95 acres, the proposed construction of the plant will be GMP standards, the factory environment clean and tidy, rational layout, with large and medium-sized production workshop and repocessed shop. It is equipped with advanced equipment quality inspection and research center. Those products of both quality and technical content have reached the domestic advanced level. Since its establishment, the company has attached great importance to the team training and technical reform. Our modern production equipment guarantees for a fast and effective production with a superior degree of accuracy throughout the whole production line, everything is done in-house, processing, extraction, packaging and transportation of all links, ensuring maximum quality and efficiency. We are constantly research and development new ingredients and innovative new products, have earned the respect & Admiration from the worldwide customers. After years of continuous development, company has been accumulated rich experience in international trade and customer resources, established a stable customer base and perfect marketing service network. In addition, the company has established long-term technical cooperation with experts and professors from many universities and research institutes in the province.

  • Inquiry History
    2098 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    tirzepatide

    10 MG Oct 30, 2026
    Brazil

    Tirzepatide

    100 G Oct 28, 2026
    Belgium

    Tirzepatide

    10 MG Oct 28, 2026
    United States

    tirzepatide

    100 MG Oct 28, 2026
    United States

    Tirzepatide

    60 MG Oct 28, 2026
    United States

    Tirzepatide

    10 PCS Oct 28, 2026
    United States

    tirzepatide

    30 MG Oct 27, 2026
    United States

    Tirzepatide

    40 MG Oct 27, 2026
    Philippines

    Tirzepatide

    2 MT Oct 27, 2026
    Philippines

    Tirzepatide

    30 MG Oct 26, 2026
    Slovakia

    Tirzepatide

    1 G Oct 26, 2026
    France

    Tirzepatide

    1 KG Oct 25, 2026
    United States

    Tirzepatide

    2.5 MG Oct 25, 2026
    United Kingdom

    Tirzepatide

    5 MT Oct 25, 2026
    United Kingdom

    Tirzepatide

    6 MT Oct 24, 2026
    Peru

    tirzepatide

    10 MG Oct 21, 2026
    Puerto Rico

    tirzepatide

    40 MG Oct 21, 2026
    United States

    Tirzepatide

    10 MT Oct 21, 2026
    South Africa

    Tirzepatide

    1 MT Oct 20, 2026
    United States

    Tirzepatide

    5 KG Oct 20, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.